Rigel Pharmaceuticals Income Statement
- Quarterly: December 2012 - September 2010 Previous Quarters
- Annual
| Income | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| Revenue | 0.00 | 0.00 | 1.50M | 0.75M | 0.00 | 4.355M | 0.3950M | 0.00 | 0.00 | 72.28M |
| Cost of Goods Sold | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 0.00 | 0.00 | 1.50M | 0.75M | 0.00 | 4.355M | 0.3950M | 0.00 | 0.00 | 72.28M |
| Total Depreciation, Amortization, Depletion Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| R&D Expense | 19.76M | 20.19M | 20.92M | 17.90M | 19.82M | 17.32M | 17.11M | 15.11M | 13.76M | 16.39M |
| G&A Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| SG&A Expense | 5.852M | 5.383M | 5.458M | 6.156M | 6.091M | 5.080M | 4.843M | 5.754M | 5.911M | 5.530M |
| Total Operating Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non Operating Interest Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Non-Operating Int Exp | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Special Income and Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Income and Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pre-Tax Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Income from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Income | -25.47M | -25.46M | -24.74M | -23.17M | -25.79M | -17.93M | -21.47M | -20.78M | -17.24M | 50.43M |
| Basic EPS | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| EPS Basic from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Basic | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Diluted EPS | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| EPS Diluted from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Diluted | -0.2984 | -0.3600 | -0.3500 | -0.3200 | -0.3615 | -0.25 | -0.3700 | -0.4000 | -0.3305 | 0.9600 |
| Shares Data | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| Average Basic Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Diluted Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
